Oregano (Origanum vulgare) has anti-Sporothrix spp. activity, including against strains that are resistant to antifungal drugs. As the studies are limited to the essential oil, the aim of this study was to evaluate the chemical, antioxidant and cytotoxic properties of polar oregano extracts and their anti-Sporothrix brasiliensis activity. Aerial plant parts were used in the preparation of 10 min (INF 10 ) and 60 min (INF 60 ) infusions, a decoction (DEC) and a hydroalcoholic extract (HAE). Six phenolic acids and four flavonoids were identified and quantified through liquid-chromatography (LC-MS). Extracts in increasing order of total phenolic and flavonoid contents were HAE<INF 60 <INF 10 <DEC and HAE<DEC<INF 60 <INF 10 , respectively. All extracts showed DPPH and ABTS radical scavenging potential (HAE<INF 60 <DEC<INF 10 ). HAE showed the least toxicity toward MDCK and CRFK cell lines in the MTT colorimetric assay. The antifungal potential against 29 S. brasiliensis isolates obtained from cats and dogs was evaluated following the CLSI M38-A2 protocol adapted to natural products. Minimum inhibitory concentration for 50% of the isolates (MIC 50 ) was 5 mg/ml for all extracts, and minimum fungicidal concentration for 50% of the isolates (MFC 50 ) was 20 mg/ml for INF 10 and 40 mg/ml for the remaining extracts. MIC 90 was 10 mg/ml for all extracts, except for DEC (20 mg/ml). MFC 90 was 40 mg/ml for INF 10 and > 40 mg/ml for the other extracts. This is the first C The Author 2017. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
Introduction
Sporotrichosis is a worldwide mycosis caused by the thermodimorphic Sporothrix schenckii complex that affects humans and domestic animals, mainly cats and dogs, and has public health relevance due its zoonotic contamination potential through scratches and bites of animals. [1] [2] [3] [4] Sporothrix brasiliensis is highly virulent and prevalent in feline sporotrichosis outbreaks. [5] [6] Although itraconazole has been successfully employed in the treatment of this disease, the emergence of antifungal resistance has been reported, prompting the search for new antifungal compounds. [6] [7] [8] Therapeutic properties have been observed in several preparations of oregano (Origanum vulgare). Largely used in culinary and widely used in folk medicine, oregano is traditionally used as carminative, expectorant, stimulant, stomachic, and to treat colic, coughs, headaches, nervousness, and irregular menstrual cycles. 9 Moreover, antioxidant, antibacterial and antifungal activities have been reported. [10] [11] O. vulgare is known to contain carvacrol, thymol, 4-terpineol and γ -terpinene metabolites with known biological activity, including against S. schenckii and S. brasiliensis. [12] [13] [14] [15] However, studies are restricted to essential oils. Thus, the aim of this study was to investigate the in vitro activity of polar extracts of O. vulgare against S. brasiliensis and to evaluate their chemical and antioxidant properties and cytotoxicity.
Methods

Plant material
Dried aerial vegetative parts of O. vulgare were purchased from Luar Sul -Indústria e Comércio de Produtos Alimentícios Ltda. (Santa Cruz do Sul, RS, Brazil).
Preparation of extracts
Infusions were prepared by immersing dried plant material (10% w/v) in boiling distilled water during 10 min (INF 10 ) and 60 min (INF 60 ), which were allowed to cool down naturally to room temperature. Decoction (DEC) was prepared immersing plant material (10% w/v) in distilled water at room temperature, followed by 10 min boiling. Thereafter, INF 10 , INF 60 and DEC were filtered through filter paper (Macherey-Nagel 615, Düren, Germany). For the hydroalcoholic extract (HAE) a tincture was prepared by immersing aerial plant parts (10% w/v) in ethyl alcohol 70% (v/v) (Jalles Machado S/A, Goianésia, GO, Brazil) during 7 days with daily mixing. Thereafter, the preparation was filtered through sterile gauze and concentrated under reduced pressure using a rotary evaporator TE-120 (Tecnal Equipamentos Científicos, Piracicaba, SP, Brazil). The evaporated volume was replenished with distilled water.
Chemical analysis
Total phenolic content
Fifteen μl of each O. vulgare extract were mixed with 240 μl of distilled water and 15 μl of Folin-Ciocalteu solution (0.25 N). The mixture was homogenized and allowed to react for 10 min. Then, 30 μl of sodium carbonate (1 N) were added and homogenized. 16 Absorbance was measured after 2 h of incubation using a microplate reader (Spectra Max 190, Molecular Devices) at 725 nm. Total phenolic compound content was calculated based on a calibration curve using gallic acid as standard, and the results were expressed in mg gallic acid equivalents/g of sample.
Total flavonoid content Following the method described by Zhishen et al., 17 30 μl of each extract were mixed with 120 μl of water and 9 μl of 5% sodium nitrite (NaNO 2 ) in the wells of a 96-well microplate and allowed to react for 5 min. Then, 9 μl of 10% aluminum chloride (AlCl 3 ) were added. After 6 min, 60 μl of sodium hydroxide (1 M) and 72 μl of distilled water were added. Absorbance was measured in a microplate reader at 510 nm, and results were expressed in mg (-)-epicatechin equivalents/g of sample.
Chromatographic analysis
O. vulgare extract samples were filtered through a 0.22 μm nylon membrane filter (Millipore). Liquid chromatographymass spectrometry (LC-MS) analysis was performed on a Prominence UFLC system (Shimadzu, Japan) coupled to MS Impact HD (Bruker Daltonics, Germany). Phenolic compounds were separated using Luna C18 reversed-phase silica 100 Åcolumn (2 × 150 mm, 100 Å, particle size 3 μm, Phenomonex, Torrance, CA USA). Solvents were 0.1% ABTS radical-scavenging potential ABTS [2,2 -azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)] radical scavenging potential was measured according to the method described by Rufino et al. 19 ABTS radical was prepared by the reaction of 5 ml of ABTS solution (7 mM) with 88 μl of potassium persulfate (140 nM) in the dark, at room temperature, for 16 h. ABTS radical solution was diluted in 1 ml ethyl alcohol to achieve an absorbance of 0.7 nm ± 0.05 nm at 734 nm. An aliquot (20 μl) of each extract was mixed with 280 μl of diluted ABTS radical solution and vortexed (Phoenix, AP-56). After 6 min of reaction, the absorbance was measured using a microplate reader. Results were expressed as percentage of antioxidant potential as previously described.
Cytotoxicity assay
Potential cytotoxic effects were determined using the colorimetric MTT [3-(4,5-dimethylthiazol-2-yl)-2, Aliquots of this cell suspension were placed in individual microplate wells, with exception of the first well, which served as a blank. Cells were incubated in E-MEM medium supplemented with 10% fetal calf serum (Gibco R , Grand Island, NY, USA) for 24 h in 5% CO 2 at 37 • C. Subsequently, 100 μl of each O. vulgare extract in 10 successive dilutions on a logarithmic scale were added to the microplate wells. Concentrations of 0.078 to 40 mg/ml diluted in E-MEM were tested in triplicate for 48 h at 37
• C in a humidified atmosphere of 5% CO 2 . E-MEM alone was used as control. Then, 50 μl of MTT solution (1 mg/ml) were added to each well and incubated for 4 h at 37
• C and 5% CO 2 . After the removal of MTT solution, 100 μl of dimethyl sulfoxide (DMSO) were added to each well to dissolve the formazan crystals. Spectrophotometric absorbance of the samples was measured using a microplate reader at 540 nm. Cells were observed in an inverted microscope, and the mean ± SD of viable cells (%) was expressed in comparison to the respective control cells.
Fungal isolates
For in vitro tests, 29 S. brasiliensis clinical isolates obtained from cats (n = 12) and dogs (n = 17) with sporotrichosis from three cities of Southern Brazil were used. Strains were identified by molecular analysis at Laboratório de Micologia Médica e Molecular (UNIFESP, São Paulo, SP, Brazil). Standard strains of S. brasiliensis (n = 1; codes: Ss 177; Table 1 . Total phenolic (mg of gallic acid equivalents/g) and total flavonoid (mg of (-)-epicatechin equivalents/g) content of
Origanum vulgare polar extracts (mean ± SD). 
Antifungal susceptibility test
In vitro antifungal test was performed using the broth microdilution method, according to the CLSI M38-A2 standard protocol, 21 with adaptations for natural products. 13 Fungal inocula of filamentous phase of Sporothrix spp. were prepared from colonies grown at 27
• C for 7 days, which were resuspended in tubes containing sterile saline and adjusted to 1.0 McFarland scale and, subsequently, in a ultraviolet(UV)-visible spectrophotometer (Spectrum Instruments Co., Shanghai, China) with transmittance adjusted to 80-82% at the fixed wavelength of 530 nm. Fungal suspensions were diluted in RPMI-1640 medium buffered with 2% glucose and MOPS [3-(N-morpholino propanesulfonic acid)] at 1:50, v/v (Sigma, Steinheim, Germany). As an adaptation of methodology, the extracts were serially diluted in RPMI-1640 with 2% glucose and MOPS in the microplate in order to obtain concentrations ranging from 0.07 to 40 mg/ml. Fungal suspension (100 μl) was added to all tested wells, including to the positive control. Extract suspensions diluted in RPMI-1640 were used as negative control. Positive control consisted of itraconazole for veterinary use (Cepav Pharma R Ltda, São Paulo, SP, Brazil), which was diluted in DMSO. Microplates were incubated at 27
• C for 72 h to obtain the results of minimum inhibitory concentration (MIC). For minimum fungicidal concentration (MFC), 10 μl aliquots of the wells with no fungal growth were transferred to Petri dishes containing Sabouraud dextrose agar (Acumedia, MI, USA) and incubated at 27
• C for 72 h to visualize fungal growth. All experiments were performed in duplicate.
Statistical analysis
Analysis of variance and comparison of geometric means were performed by the Kruskal-Wallis test followed by Dunn's multiple-comparison test for antifungal assays and Fisher's Least Significant Difference (LSD) test for cytotoxic analyses. Data were analyzed using the statistical software BioEstat R (version 5.3), and a P value of .05 was considered significant.
Results
Chemical analysis
Total phenolic and flavonoid content of O. vulgare extracts are shown in Table 1 . A higher total phenolic content was observed in relation to total flavonoid content for all extracts, except for INF 10 . (Table 2) , and 4-hydroxybenzoic acid was the most abundant phenolic acid in all preparations. Syringic acid was the second major compound found in all samples, except for the HAE, which had caffeic acid as the second most abundant identified phenolic compound. Hesperetin was the most abundant flavonoid found in all extracts. Luteolin was detected only in HAE (Table 2) .
Antioxidant potential
The antioxidant potential of O. vulgare extracts was evaluated by the DPPH and ABTS free radical scavenging methods ( Table 3 ). The infusions (INF 10 and INF 60 ) and HAE presented similar potential in both assays, while DEC had higher scavenging potential against ABTS than against DPPH. INF 10 presented the highest antioxidant potential, whereas HAE showed the lowest potential. DEC presented a higher antioxidant potential than INF 60 . The increasing order of antioxidant potential in both performed assays was HAE<INF 60 <DEC<INF 10 .
Cell viability
The percentage of viability of CRFK (Fig. 1) and MDCK (Fig. 2) cell lines was inversely proportional to the concentration of all tested O. vulgare extracts. For INF 10 and DEC, the viability of CRFK and MDCK cells was greater than 70% in concentrations up to 0.625 mg/ml and 0.156 mg/ml, respectively. However, percent cell viability differed significantly (sP < .01) at concentrations ≥1.25 mg/ml for CRFK (62.64 ± 1.8 for INF 10 the CRFK cells remained viable up to 1.25 mg/ml, and more than 80% of the MDCK cells remained viable up to 0.625 mg/ml; and statistical difference in comparison to control cells was showed at concentration ≥2.5 mg/ml (64.91 ± 3.97) for CRFK and ≥1.25 mg/ml (42.62 ± 4.13) for MDCK. Conversely, HAE presented less potential cytotoxicity when compared to aqueous extracts because more than 70% of CRFK and MDCK cell lines remained viable at concentrations up to 5 mg/ml and up to 2.5 mg/ml, respectively. At concentrations ≤10 mg/ml for CRFK (16.56 ± 4.18) and ≤5 mg/ml for MDCK (15.79 ± 4.09), HAE differed from the control cells (P < .01) ( Table 4) .
Anti-Sporothrix spp. activity
All tested extracts presented inhibitory activity against all Sporothrix spp. Against S. brasiliensis, MIC 50 and MIC 90 were 5 mg/ml and 10 mg/ml, respectively, for infusions and HAE, and 5 mg/ml and 20 mg/ml, respectively, for DEC. MIC values for S. schenckii were lower, ranging from ≤ 0.07 to 2.5 mg/ml (Table 5 ). No statistical difference was observed among the extracts, except for INF 60 , which presented stronger inhibitory activity than DEC (P < .05).
Boiling time did not interfere in the anti-Sporothrix spp. activity of the infusions (P > .05). MIC values for itraconazole ranged between 0.06 and > 16 μg/ml for S. brasiliensis isolates, and susceptibility of S. brasiliensis to the drug was observed only for 75% (09/12) and 70.6% (12/17) of the isolates obtained from cats and dogs, respectively. MIC values of itraconazole against standard strains were 16 μg/ml for S. brasiliensis and 0.12 μg/ml for S. schenckii. The remaining isolates were resistant to the maximum concentration tested, indicating antifungal resistance. No fungicidal activity was observed for itraconazole (MFC > 16 μg/ml).
Discussion
The flavonoids hesperetin, quercetin and rutin observed in all oregano extracts have been previously reported to have antifungal activity against Aspergillus spp., Fusarium spp., Penicillium spp., Candida albicans, and Malassezia pachydermatis. [22] [23] [24] [25] In all extracts, except for INF 10 , the phenolic content was higher than the flavonoid content, which is in accordance to the findings of Kulisic et al. 26 Martins et al. 27 also studied the same type of extracts and found a higher proportion of total flavonoid content when compared to total phenolic content, in line with that found in INF 10 .
Chemical composition of the extracts may be influenced by many factors, such as cultivation area, genetic variability and extraction methodology. 28 Syringic, caffeic, and 4-hydroxybenzoic acids were found in all extracts and had been previously observed in Table 5 . Minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of Origanum vulgare polar extracts and itraconazole against Sporothrix schenckii complex obtained from humans and animals. water and ethanol extracts of oregano from Romania. 29 Antifungal activity of the cited compounds has been previously reported [30] [31] [32] and could explain the antifungal activity against Sporothrix spp., mainly by 4-hydroxybenzoic acid, which was the predominant compound in all extracts. The antifungal activity of this benzoic acid derivative has been attributed to its molecular arrangement, since a displacement of the hydroxyl group on the aromatic ring reduces its antifungal activity. 33 During the microbial pathogenesis, the functioning of the immune system, for example, phagocytosis, generates reactive oxygen species that may affect the defense cells due to the hostile environment. The use of antioxidant components may help the immunomodulatory response, preserving the phagocytosis. 34, 35 In this sense, the relevant radical scavenging potential of oregano extracts may play an important role in the antifungal activity. The presence of compounds containing phenolic hydroxyl groups which are capable of stabilizing free radicals may account for the antioxidant potential. 36 Aqueous extracts showed higher potential than HAE, in agreement with findings by Kaurinovic et al. 37 and Martins et al. 27 The lower concentration of phenolic and flavonoid contents found in HAE reflects its lower antioxidant capacity. In addition, INF 10 also had the highest antioxidant capacity. In extracts infused for different period of times (10 and 60 min), the increased time seemed to be inversely proportional to the antioxidant potential, which may be explained by the reduced flavonoid content. Oregano extracts are known to exert low cell damage 38 and their clinical safety should be considered for therapeutic use. The findings of this study are in agreement with Khan et al. 39 that also showed no toxic effects of oregano extracts against MDCK cells at 0.1 mg/ml or against human alveolar type II-like epithelial cells (A549) at 7.8 μg/ml. 40 In the extracts, HAE seemed to be safer than the aqueous products when concentrations equal or below to 5 mg/ml and 2.5 mg/ml were evaluated on CRFK and MDCK cell lines, respectively. These findings along with those found in the susceptibility tests suggest a promising use of HAE as antifungal agent. Cytotoxicity test is an important indicator for toxicity evaluation through tissue cells in vitro and has a high sensitivity. 41 However, for promoting a high exposure to the product, this test renders the cells more prone to the possible deleterious effects of the substance tested. 42 Although the highest concentrations of oregano extracts showed toxicity for cell lines, their use may not be toxic in vivo and the clinical safe of oregano infusion offered ad libitum to Wistar rats was proven during 30 days as only fluid intake, 43 showing the promising use of extracts in animals. Nevertheless, further studies should be undertaken to evaluate the adverse effects of these extracts in animal models of sporotrichosis and to study their in vivo antifungal activity. This study is the first to evaluate the anti-Sporothrix spp. activity of aqueous and hydroalcoholic oregano extracts. Our findings are in accordance to studies with oils tested against S. brasiliensis 15 and S. schenckii [12] [13] The findings of this study demonstrate the potential of oregano extracts in the treatment of sporotrichosis. AntiSporothrix spp. potential was observed against all strains tested, including against itraconazole-resistant S. brasiliensis isolates. All oregano extracts presented antioxidant potential and low cytotoxicity, especially the HAE, which also had the least amount of total phenolic and flavonoid content despite being the richest in the analyzed individual phenolic compounds. The findings support potential usefulness of these extracts in the treatment of sporotrichosis. Further studies should be undertaken to evaluate their safe use in this mycosis.
